Company Overview

Milestone Scientific Inc. is a medical and dental technology company that develops, manufactures, and markets proprietary computer-controlled injection systems designed to improve the safety, accuracy, and patient comfort of local anesthesia delivery. The company operates primarily within the medical devices and dental equipment industries, with a focus on pain management and diagnostic pressure-sensing technologies. Its core products are used by dental professionals and physicians to enhance procedural outcomes and reduce patient discomfort.

The company’s primary revenue drivers are its patented anesthesia delivery platforms, most notably the STA Single Tooth Anesthesia System and pressure-sensing technologies used in both dental and medical applications. Milestone Scientific positions itself through proprietary technology that integrates real-time pressure feedback and computer-assisted control, which differentiates its systems from traditional manual injection methods. The company traces its origins to the late 1990s, evolving from early research in controlled drug delivery into a specialized developer of niche, high-precision medical devices.

Business Operations

Milestone Scientific operates through integrated research, development, manufacturing oversight, and commercial distribution of its medical and dental systems. Its core business centers on the design and commercialization of proprietary hardware and software platforms that control fluid flow and pressure during injections. Revenue is primarily generated through system sales, consumables, and related accessories to dental practices, hospitals, and specialty medical providers.

Operations are conducted through the parent company and its wholly owned subsidiary Milestone Scientific Ltd., which serves as the company’s primary research and development arm. The company sells products in the United States and internationally through a combination of direct sales efforts and independent distributors. Its technology portfolio includes patented pressure-sensing algorithms and disposable components that create recurring revenue opportunities alongside capital equipment sales.

Strategic Position & Investments

Milestone Scientific’s strategy focuses on expanding adoption of its core platforms within dentistry while extending its pressure-sensing technology into broader medical applications. Growth initiatives have historically emphasized regulatory clearances, intellectual property development, and targeted commercialization efforts in specialized clinical markets rather than large-scale mass distribution. The company has also pursued clinical validation to support differentiation based on safety and efficacy.

Investment activity has primarily centered on internal product development rather than large acquisitions. The company continues to invest in next-generation iterations of its core systems and software enhancements intended to support new clinical indications. Public disclosures indicate that expansion into additional medical use cases remains a strategic objective, though the timing and scale of such expansion are subject to available capital and regulatory considerations.

Geographic Footprint

Milestone Scientific is headquartered in the United States, with operational and commercial activity spanning North America, Europe, and parts of Asia-Pacific through distributor relationships. The company maintains a significant development presence in Israel via Milestone Scientific Ltd., which supports engineering, software development, and intellectual property creation.

International sales are conducted primarily through third-party distributors, allowing the company to maintain a global market presence without extensive physical infrastructure abroad. While the United States remains its largest market, international operations represent a meaningful component of its long-term growth strategy.

Leadership & Governance

Milestone Scientific is led by executives with experience in medical devices, technology commercialization, and corporate finance. Leadership has emphasized disciplined capital management, protection of intellectual property, and incremental market expansion driven by clinical validation and practitioner adoption.

Key executives include:

• Leonard Osser – Chief Executive Officer
• Leonard Osser – President
• Joseph A. Tomasulo – Chief Financial Officer
• Amit Gelfand – Vice President of Research and Development

The company is governed by a board of directors that provides oversight on strategy, regulatory compliance, and shareholder interests. Leadership communications consistently highlight a focus on innovation-driven growth, regulatory discipline, and long-term value creation.